In contrast, a high density of intra-tumor CD169+ Mφs predicted favorable survival in both HCC (P = 0.01) and GC (P = 0.027; Fig. 3b) patients (Additional files 2, 3). This evidence concerns the gene SIGLEC1 and neoplasm.